Kartikeya Makker

Medicine & Life Sciences

1. Premature Infants 100%
2. Extremely Premature Infants 68%
3. Necrotizing Enterocolitis 65%
4. Patent Ductus Arteriosus 58%
5. Ibuprofen 55%
6. Neonatal Intensive Care Units 55%
7. Acetaminophen 50%
8. Parturition 42%
9. Interactive Ventilatory Support 40%
10. Sepsis 39%
11. Extremely Low Birth Weight Infant 39%
12. Persistent Fetal Circulation Syndrome 35%
13. Supervisory Nursing 35%
14. Quality Improvement 34%
15. Gestational Age 31%
16. Growth 31%
17. Obesity 28%
18. Positive-Pressure Respiration 27%
19. Adipokines 27%
20. Intracranial Hemorrhages 26%
21. Mothers 25%
22. Pediatric Obesity 25%
23. Surface-Active Agents 24%
24. Primary Prevention 24%
25. Leptin 23%
26. Patient Safety 23%
27. Hypoglycemia 23%
28. Overweight 22%
29. Acute Kidney Injury 22%
30. Adiponectin 22%
31. Milk 22%
32. Mortality 21%
33. Gels 19%
34. Medical Overuse 19%
35. Hypoxia 18%
36. Asthma 18%
37. Meta-Analysis 17%
38. Systematic Reviews 17%
39. Disclosure 17%
40. Pediatrics 16%
41. Insulin 16%
42. Child 15%
43. Anti-Bacterial Agents 15%
44. Glucose 15%
45. Hispanic Americans 14%
46. African Americans 13%
47. European Continental Ancestry Group 13%
48. Pulmonary Artery 13%
49. Endothelial Cells 12%
50. Infections 12%